Celeste Letourneau
FDA Draft Guidance on Safety Data Collection for Late Stage Premarket & Postmarket Investigations
Health Industry Washington Watch ·
CMS and FDA Announce Parallel Review Pilot Program
Life Sciences Legal Update ·
Prospects Unclear for CMS/FDA Proposed Parallel Review of Medical Products
Life Sciences Legal Update ·